MAKSIM MAMONKIN to Hematologic Neoplasms
This is a "connection" page, showing publications MAKSIM MAMONKIN has written about Hematologic Neoplasms.
Connection Strength
0.427
-
Engineering naturally occurring CD7- T cells for the immunotherapy of hematological malignancies. Blood. 2022 12 22; 140(25):2684-2696.
Score: 0.162
-
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022 07 07; 140(1):16-24.
Score: 0.157
-
[CAR T-cell therapy: Balance of efficacy and safety]. Mol Biol (Mosk). 2017 Mar-Apr; 51(2):274-287.
Score: 0.108